| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |